糖尿病患者的主观嗅觉和味觉丧失——一项基于问卷调查的研究,涉及47011名糖尿病患者和匹配的对照组。

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Alexander Wieck Fjaeldstad, Kasper Norman, Lasse Bjerg
{"title":"糖尿病患者的主观嗅觉和味觉丧失——一项基于问卷调查的研究,涉及47011名糖尿病患者和匹配的对照组。","authors":"Alexander Wieck Fjaeldstad, Kasper Norman, Lasse Bjerg","doi":"10.1111/dom.70099","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Taste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self-reported taste and smell dysfunction in individuals with diabetes and explore associations with clinical and behavioural factors.</p><p><strong>Methods: </strong>We examined self-reported taste and smell disorders in 47,011 individuals with or without diabetes using data from the Health in Central Denmark (HICD) cohort. In total, eight questions on subjective smell and taste function were included in the questionnaire.</p><p><strong>Results: </strong>Participants with type 2 diabetes reported significantly more qualitative and quantitative chemosensory complaints than matched controls. In contrast, no significant differences were found between individuals with Type 1 Diabetes and controls. Smoking was consistently associated with increased complaints across all groups, while HbA1c levels showed no correlation with taste or smell disorders. Obesity, particularly in women with diabetes, was linked to higher symptom reporting CONCLUSIONS: Individuals with type 2 diabetes report more chemosensory complaints than controls. Smoking and obesity, but not HbA1c, were associated with a higher prevalence of symptoms. As subjective rating tends to underestimate true prevalence, future research should include objective testing to clarify how chemosensory disorders affect dietary behaviour and diabetes management.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Subjective smell- and taste loss in diabetes-A questionnaire-based study on 47 011 individuals with diabetes and matched controls.\",\"authors\":\"Alexander Wieck Fjaeldstad, Kasper Norman, Lasse Bjerg\",\"doi\":\"10.1111/dom.70099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Taste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self-reported taste and smell dysfunction in individuals with diabetes and explore associations with clinical and behavioural factors.</p><p><strong>Methods: </strong>We examined self-reported taste and smell disorders in 47,011 individuals with or without diabetes using data from the Health in Central Denmark (HICD) cohort. In total, eight questions on subjective smell and taste function were included in the questionnaire.</p><p><strong>Results: </strong>Participants with type 2 diabetes reported significantly more qualitative and quantitative chemosensory complaints than matched controls. In contrast, no significant differences were found between individuals with Type 1 Diabetes and controls. Smoking was consistently associated with increased complaints across all groups, while HbA1c levels showed no correlation with taste or smell disorders. Obesity, particularly in women with diabetes, was linked to higher symptom reporting CONCLUSIONS: Individuals with type 2 diabetes report more chemosensory complaints than controls. Smoking and obesity, but not HbA1c, were associated with a higher prevalence of symptoms. As subjective rating tends to underestimate true prevalence, future research should include objective testing to clarify how chemosensory disorders affect dietary behaviour and diabetes management.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.70099\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70099","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:味觉和嗅觉障碍在糖尿病患者中更为常见,尤其是那些胰岛素敏感性低或中心性肥胖的患者。这些疾病可以通过改变饮食习惯来影响血糖控制。本研究旨在调查糖尿病患者自我报告的味觉和嗅觉功能障碍,并探讨其与临床和行为因素的关系。方法:我们使用来自丹麦中部健康(HICD)队列的数据,检查了47,011名患有或不患有糖尿病的个体自我报告的味觉和嗅觉障碍。问卷共包含8个关于主观嗅觉和味觉功能的问题。结果:与对照组相比,2型糖尿病患者报告了更多的定性和定量化学感觉不适。相比之下,在1型糖尿病患者和对照组之间没有发现显著差异。在所有人群中,吸烟都与投诉增加有关,而糖化血红蛋白水平与味觉或嗅觉障碍无关。结论:与对照组相比,2型糖尿病患者报告的化学感觉不适更多。吸烟和肥胖,但与糖化血红蛋白无关,与更高的症状发生率相关。由于主观评价倾向于低估真实患病率,未来的研究应包括客观测试,以阐明化学感觉障碍如何影响饮食行为和糖尿病管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Subjective smell- and taste loss in diabetes-A questionnaire-based study on 47 011 individuals with diabetes and matched controls.

Background: Taste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self-reported taste and smell dysfunction in individuals with diabetes and explore associations with clinical and behavioural factors.

Methods: We examined self-reported taste and smell disorders in 47,011 individuals with or without diabetes using data from the Health in Central Denmark (HICD) cohort. In total, eight questions on subjective smell and taste function were included in the questionnaire.

Results: Participants with type 2 diabetes reported significantly more qualitative and quantitative chemosensory complaints than matched controls. In contrast, no significant differences were found between individuals with Type 1 Diabetes and controls. Smoking was consistently associated with increased complaints across all groups, while HbA1c levels showed no correlation with taste or smell disorders. Obesity, particularly in women with diabetes, was linked to higher symptom reporting CONCLUSIONS: Individuals with type 2 diabetes report more chemosensory complaints than controls. Smoking and obesity, but not HbA1c, were associated with a higher prevalence of symptoms. As subjective rating tends to underestimate true prevalence, future research should include objective testing to clarify how chemosensory disorders affect dietary behaviour and diabetes management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信